Navigation Links
Aimed at Medical Device Makers, FDA Software Development Company Full Spectrum Releases Free Technical Report on Software Protection Technology
Date:12/9/2008

Full Spectrum - a leading FDA software development company - provides medical device makers with the latest information on code obfuscation technology in their latest free technical report, available now.

(PRWEB) December 9, 2008 -- With their most recent technical report, leading FDA software development company Full Spectrum informs medical device companies of the impact of using a basic software engineering technique called code obfuscation when protecting their technology.

As a leading provider of software development services for the medical device industry, Full Spectrum is at the forefront of software protection technology. Available now, their comprehensive technical report expounds on how to use the software engineering technology called code obfuscation to prevent reverse engineering of highly valuable code, prevent patent disputes, and sell into emerging markets with confidence.

For many makers of sophisticated medical devices, simply complying with all of the necessary FDA guidelines is a major hurdle. However, of equal importance is making sure that their complicated software cannot be reverse engineered. Without the appropriate software protection technology, expensive code that can cost up to millions of dollars to develop and test, is easily stolen.

Highly underutilized by the medical device industry, software code obfuscation is used by both extremely sensitive government organizations as well as consumer products companies. Recent studies show that less than seven percent of medical device companies use this well known technology. Therefore, in an effort to educate this industry on the importance of code obfuscation and the business benefits associated with it, Full Spectrum and PreEmptive Solutions, a leading provider of code obfuscation technology and toolsets, have collaborated to produce a thorough report on the subject.

Out now, this free report contains a complete overview of code obfuscation technology, including an overview for non-technical executives and a more detailed description for technical managers.

For a limited time, the report is available free on Full Spectrum Software's website. No registration is required.

For additional technical information on code obfuscation technology, please visit PreEmptive Solution's web site at www.preemptive.com.

Medical device companies wishing to learn more about FDA software development company Full Spectrum can visit www.FullSpectrumSoftware.com

Media contact:
Ken Carson
kcarson(at)fullspectrumsoftware.com
617-834-9217

###

Read the full story at http://www.prweb.com/releases/2008/12/prweb1694814.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Related medicine news :

1. CHPA Commends Senator Biden on Legislation Aimed at Curbing Medicine-Abuse Trend
2. Abt Associates to Lead Major Evaluation of Programs Aimed at Promoting Self-Sufficiency for Disadvantaged Families
3. Free Book: Critically Acclaimed Book on Anger Management Now Available in Both Unabridged Audio and Print Form Worldwide
4. Congress Poised to Reauthorize Legislation Aimed at Dramatic Expansion of Global HIV and AIDS Programs
5. IRC Reports Claimed Medical Expenses for Auto Injury Claimants Far Outpace Inflation
6. GenOdyssee Receives Notice of Allowance from U.S. Patent Office for Improved Interferon-Alpha Aimed at Hepatitis C
7. Anthem Blue Cross and Blue Shield in Wisconsin Announces Initiative Aimed at Preventing Serious Medical Errors; Company Committed to Protecting Members Health and Finances by Not Reimbursing Major Preventable Adverse Events
8. Empire Blue Cross Blue Shield Announces Initiative to Protect Members Health Aimed at Preventing Serious Medical Errors
9. Anthem Blue Cross Announces Initiative Aimed at Preventing Serious Medical Errors; Company Committed to Protecting Members Health and Finances by Not Reimbursing Major Preventable Adverse Events
10. Acclaimed A LION IN THE HOUSE Team Honored in Washington for Pioneering Work on Pediatric Cancer
11. Internationally Acclaimed Music and Medicine Program Comes to Chaska
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Aimed at Medical Device Makers, FDA Software Development Company Full Spectrum Releases Free Technical Report on Software Protection Technology
(Date:1/22/2017)... TX (PRWEB) , ... January 22, 2017 , ... ... provide slow results. Often the results of a simple test will take days to ... Any Lab Test Now offers customers direct access to their lab tests, bypassing the ...
(Date:1/21/2017)... (PRWEB) , ... January 21, 2017 , ... Phytocéane ... Indian Ocean, isolated from the rest of the world with ZANZIBAR SHOWER GEL. Inspired ... Phytocéane used key ingredients, Virgin Coconut Oil and moisturizing vegetal coral to create this ...
(Date:1/21/2017)... ... January 21, 2017 , ... The Nobel ... Dan Holtzclaw in media for its creos™ line of bone regenerative products. ... Holtzclaw in which he utilizes creos™ allo.gain™ bone graft for a variety of ...
(Date:1/20/2017)... , ... January 20, 2017 , ... Doctor C LLC, ... attended the January ECRM trade show to continue the marketing and distribution of its ... supplement, known for providing 400 percent better absorption than traditional vitamin C supplements. At ...
(Date:1/20/2017)... ... January 20, 2017 , ... Michael and Betsy Brauser celebrated 5 years ... Betsy, the clinical trial has been life-saving as she has been on the ... Betsy Brauser was diagnosed with ovarian cancer in 2009. She underwent standard chemotherapy but ...
Breaking Medicine News(10 mins):
(Date:1/21/2017)... 2017 ResMed (NYSE: RMD ), BMC ( ... Haven, Florida ) today announced they have agreed on a ... will be permitted to sell their existing products in exchange for ... payment to 3B to close the Florida ... admission of liability or wrongdoing by any party. ...
(Date:1/21/2017)... , Jan. 20, 2017 ARMO BioSciences, Inc., ... data on the Company,s lead investigational immuno-oncology drug AM0010 ... by the American Society of Clinical Oncology (ASCO), taking ... CA. "AM0010 induces the ... + T cells in the blood and tumors ...
(Date:1/21/2017)... -- Research and Markets has announced the addition of ... Route Of Administration, End User - Forecast to 2025" report ... ... a CAGR of around 7.8% over the next decade to reach ... analyzes the global markets for Advanced Drug Delivery across all the ...
Breaking Medicine Technology: